Tumor Suppressors Status in Cancer Cell Line Encyclopedia

被引:22
|
作者
Sonkin, Dmitriy [1 ]
Hassan, Mehedi [1 ]
Murphy, Denis J. [1 ]
Tatarinova, Tatiana V. [1 ,2 ]
机构
[1] Univ South Wales, Pontypridd CF37 1DL, M Glam, Wales
[2] Univ So Calif, Lab Appl Pharmacokinet, Los Angeles, CA 90089 USA
关键词
Tumor suppressor; Cancer cell line; CCLE; Loss of function; DNA methylation; Epigenetics; DATABASE; GENE; MDM2; MUTATION; PATHWAY; SAMPLES; TP53;
D O I
10.1016/j.molonc.2013.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor suppressors play a major role in the etiology of human cancer, and typically achieve a tumor-promoting effect upon complete functional inactivation. Bi-allelic inactivation of tumor suppressors may occur through genetic mechanisms (such as loss of function mutation, copy number (CN) loss, or loss of heterozygosity (LOH)), epigenetic mechanisms (such as promoter methylation or histone modification), or a combination of the two. We report systematically derived status of 69 known or putative tumor suppressors, across 799 samples of the Cancer Cell Line Encyclopedia. In order to generate such resource we constructed a novel comprehensive computational framework for the assessment of tumor suppressor functional "status". This approach utilizes several orthogonal genomic data types, including mutation data, copy number, LOH and expression. Through correlation with additional data types (compound sensitivity and gene set activity) we show that this integrative method provides a more accurate assessment of tumor suppressor status than can be inferred by expression, copy number, or mutation alone. This approach has the potential for a more realistic assessment of tumor suppressor genes for both basic and translational oncology research. (C) 2013 Federation. of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:791 / 798
页数:8
相关论文
共 50 条
  • [1] Quantitative Proteomics of the Cancer Cell Line Encyclopedia
    Nusinow, David P.
    Szpyt, John
    Ghandi, Mahmoud
    Rose, Christopher M.
    McDonald, E. Robert, III
    Kalocsay, Marian
    Jane-Valbuena, Judit
    Gelfand, Ellen
    Schweppe, Devin K.
    Jedrychowski, Mark
    Golji, Javad
    Porter, Dale A.
    Rejtar, Tomas
    Wang, Y. Karen
    Kryukov, Gregory, V
    Stegmeier, Frank
    Erickson, Brian K.
    Garraway, Levi A.
    Sellers, William R.
    Gygil, Steven P.
    CELL, 2020, 180 (02) : 387 - +
  • [2] Thyroid Hormone Receptors as Tumor Suppressors in Cancer
    Zhu, Xuguang
    Cheng, Sheue-yann
    ENDOCRINOLOGY, 2024, 165 (10)
  • [3] Next-generation characterization of the Cancer Cell Line Encyclopedia
    Ghandi, Mahmoud
    Huang, Franklin W.
    Jane-Valbuena, Judit
    Kryukov, Gregory V.
    Lo, Christopher C.
    McDonald, E. Robert, III
    Barretina, Jordi
    Gelfand, Ellen T.
    Bielski, Craig M.
    Li, Haoxin
    Hu, Kevin
    Andreev-Drakhlin, Alexander Y.
    Kim, Jaegil
    Hess, Julian M.
    Haas, Brian J.
    Aguet, Francois
    Weir, Barbara A.
    Rothberg, Michael V.
    Paolella, Brenton R.
    Lawrence, Michael S.
    Akbani, Rehan
    Lu, Yiling
    Tiv, Hong L.
    Gokhale, Prafulla C.
    De Weck, Antoine
    Mansour, Ali Amin
    Oh, Coyin
    Shih, Juliann
    Hadi, Kevin
    Rosen, Yanay
    Bistline, Jonathan
    Venkatesan, Kavitha
    Reddy, Anupama
    Sonkin, Dmitriy
    Liu, Manway
    Lehar, Joseph
    Korn, Joshua M.
    Porter, Dale A.
    Jones, Michael D.
    Golji, Javad
    Caponigro, Giordano
    Taylor, Jordan E.
    Dunning, Caitlin M.
    Creech, Amanda L.
    Warren, Allison C.
    McFarland, James M.
    Zamanighomi, Mahdi
    Kauffmann, Audrey
    Stransky, Nicolas
    Imielinski, Marcin
    NATURE, 2019, 569 (7757) : 503 - +
  • [4] Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration
    Heering, Johanna
    Erlmann, Patrik
    Olayioye, Monilola A.
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (15) : 2505 - 2514
  • [5] Inhibitor of growth tumor suppressors in cancer progression
    Piche, Brad
    Li, Gang
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (12) : 1987 - 1999
  • [6] Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer
    Rodrigues-Ferreira, Sylvie
    Molina, Angie
    Nahmias, Clara
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 267 - 273
  • [7] Inhibitor of growth tumor suppressors in cancer progression
    Brad Piche
    Gang Li
    Cellular and Molecular Life Sciences, 2010, 67 : 1987 - 1999
  • [8] BTG2: A rising star of tumor suppressors
    Mao, Bijing
    Zhang, Zhimin
    Wang, Ge
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (02) : 459 - 464
  • [9] Tumor suppressors: enhancers or suppressors of regeneration?
    Pomerantz, Jason H.
    Blau, Helen M.
    DEVELOPMENT, 2013, 140 (12): : 2502 - 2512
  • [10] Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer
    Laczmanska, Izabela
    Sasiadek, Maria M.
    ACTA BIOCHIMICA POLONICA, 2011, 58 (04) : 467 - 470